SUMITOMO PHARMA CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 4506 for the last quarter is 79.53 B JPY, and it's 3.47% lower compared to the previous quarter. The net income of Q4 23 is -197.26 B JPY.